The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL

The receptor activator of nuclear factor-κB (RANK) and the RANK ligand (RANKL) were reported in the regulation of osteoclast differentiation/activation and bone homeostasis. Additionally, the RANKL/RANK axis is a significant mediator of progesterone-driven mammary epithelial cell proliferation, pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Simatou, Aristofania, Sarantis, Panagiotis, Koustas, Evangelos, Papavassiliou, Athanasios G., Karamouzis, Michalis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590202/
https://www.ncbi.nlm.nih.gov/pubmed/33066388
http://dx.doi.org/10.3390/ijms21207570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590202/
https://www.ncbi.nlm.nih.gov/pubmed/33066388
http://dx.doi.org/10.3390/ijms21207570

Ejemplares similares